Vaxart, Inc. (VXRT) stock

VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30

$0.48+0.02 (+5.04%)

Close on Oct 19, 2026Market cap $115.61MP/E 4.0Yield –

Vaxart price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Vaxart's price to book ratio was 1.4× on Oct 19, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.9× to 5.0×, with a median of 2.1×.

Price to Book Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	1.4×	−1.6
2025	Dec 31, 2025	3.0×	+0.8
2024	Dec 31, 2024	2.2×	+1.0
2023	Dec 29, 2023	1.2×	+0.2
2022	Dec 30, 2022	1.0×	−2.8
2021	Dec 31, 2021	3.8×	−0.9
2020	Dec 31, 2020	4.7×	+3.9
2019	Dec 31, 2019	0.9×	+0.0
2018	Dec 31, 2018	0.8×	−4.4
2017	Dec 29, 2017	5.2×	−6.1
2016	Dec 30, 2016	11.3×	−1.7
2015	Dec 31, 2015	13.0×	+1.9
2014	Dec 31, 2014	11.1×	−9.0
2013	Dec 31, 2013	20.1×	−13.1
2012	Dec 31, 2012	33.3×	−31.2
2011	Dec 30, 2011	64.5×	−134.1
2010	Dec 31, 2010	198.6×	–